A blood pump system intended for short-term management of cardiogenic shock (non-responsive to medical management) or severe cardio-respiratory insufficiency in adult and paediatric patients
NICE has now published a Medtech Innovation Briefing on the Levitronix centrimag.
- Status:
- Discontinued
- Decision:
- Prioritised
- Process:
- MTG
- Referral date:
- 01 February 2010
- Topic area
- Cardiovascular, Surgical procedures, Therapeutic procedures
Project Team
- Project lead
- N/A
Stakeholders
NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance on this technology, please complete a stakeholder registration and confidentiality form (Word), and return to us at medtech@nice.org.uk.
Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.
Related links
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 27 January 2017 | Discontinued. NICE has now published a Medtech Innovation Briefing on the Levitronix centrimag. |
For further information on our processes and methods, please see our CHTE processes and methods manual